96673 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in - , according to the moiety having normal peptide bonds
CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#2BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND METHODS OF USE THEREOF
#3CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS
#4RADIOMETAL-BINDING COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER
#5PROCESS FOR THE PREPARATION OF TUBULYSINS AND INTERMEDIATES THEREOF
#6CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#7Conjugates of quaternized tubulysin compounds
#8Bispecific antigen binding molecules that bind HER2, and methods of use thereof
#9Compounds
#10CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#11CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#12NOVEL RADIOMETAL-BINDING COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER
#13Process for the preparation of tubulysins and intermediates thereof
#14Peptide-Based Quorum Sensing Inhibitors for the Attenuation of Virulence in Staphylococcus Aureus
#15Small molecule DCN1 inhibitors and therapeutic methods using the same
#16Compounds
#17CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#18Cytotoxic tubulysin compounds for conjugation
#19Conjugates of quaternized tubulysin compounds
#20CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#21CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#22Conjugates for treating diseases caused by PSMA expressing cells
#23CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#24CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#25CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#26CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#27Desacetoxytubulysin H and analogs thereof
#28BINDING LIGAND LINKED DRUG DELIVERY CONJUGATES OF TUBULYSINS
#29Method of inhibiting activity of cell surface fibroblast activation protein alpha
#30Conjugates for treating diseases caused by PSMA expressing cells
#31Cytotoxic tubulysin compounds for conjugation
#32Tubulysin derivatives
#33PEPTIDE-BASED QUORUM SENSING INHIBITORS FOR THE ATTENUATION OF VIRULENCE IN STAPHYLOCOCCUS AUREUS
#34Tubulysins and processes for preparing
#35Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#36Conjugates for treating diseases caused by PSMA expressing cells
#37Tubulysin derivatives
#38Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#39Hepatocyte growth factor mimics as therapeutic agents
#40Oligopeptides and process for preparation thereof
#41Tubulysin analogues
#42Hepatocyte growth factor mimics as therapeutic agents
#43Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#44Tubulysine derivatives
#45Cyclic azapeptides as integrin markers and methods of using
#46Bioactive pre-tubulysins and use thereof
#47Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
#48Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
#49Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#50Reagent for introduction of protein or gene
#51Tubulysins and processes for preparing
#52Pleuromutilin derivatives and their use as antimicrobials
#53Binding ligand linked drug delivery conjugates of tubulysins
#54Tri-peptide Inhibitors of Serine Elastases
#55Anti-cancer compounds
#56Cyclic azapeptides as integrin markers
#57Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II
#58Variants of the PapM polypeptide of bacteria of the genus
#59SH2 domain binding inhibitors
#60Myd88 Homodimerization Inhibitors
#61Substituted sulfonamides and ureas useful for inhibiting kinase activity
#62Substituted sulfonamides and ureas useful for inhibiting kinase activity
#63Pyrrolidine melanocortin-specific compounds
#64Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
#65Beta-sheet mimetics and methods relating to the use thereof
#66β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
#67Anti-cancer compounds
#68Tubulysins, method for producing the same and tubulysin preparations
#69Low molecular weight peptidomimetic growth hormone secretagogues
#70Cell adhesion inhibitors
#71Alpha-4 beta-1 integrin ligands for imaging and therapy
#72Hpma-polyamine conjugates and uses therefore
#73Tubulysin conjugates
#74Tubulysin analogues
#75Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#76Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same
#77SH2 domain binding inhibitors
#78Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
#79Somatostatin antagonists and agonists that act at the sst subtype 2 receptor